558 related articles for article (PubMed ID: 16697729)
1. Evidence-based incorporation of serum sodium concentration into MELD.
Biggins SW; Kim WR; Terrault NA; Saab S; Balan V; Schiano T; Benson J; Therneau T; Kremers W; Wiesner R; Kamath P; Klintmalm G
Gastroenterology; 2006 May; 130(6):1652-60. PubMed ID: 16697729
[TBL] [Abstract][Full Text] [Related]
2. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
[TBL] [Abstract][Full Text] [Related]
3. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
[TBL] [Abstract][Full Text] [Related]
4. Serum sodium predicts mortality in patients listed for liver transplantation.
Biggins SW; Rodriguez HJ; Bacchetti P; Bass NM; Roberts JP; Terrault NA
Hepatology; 2005 Jan; 41(1):32-9. PubMed ID: 15690479
[TBL] [Abstract][Full Text] [Related]
5. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
6. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
[TBL] [Abstract][Full Text] [Related]
7. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.
Ruf AE; Kremers WK; Chavez LL; Descalzi VI; Podesta LG; Villamil FG
Liver Transpl; 2005 Mar; 11(3):336-43. PubMed ID: 15719386
[TBL] [Abstract][Full Text] [Related]
8. Impact of preoperative serum sodium concentration in living donor liver transplantation.
Fukuhara T; Ikegami T; Morita K; Umeda K; Ueda S; Nagata S; Sugimachi K; Gion T; Yoshizumi T; Soejima Y; Taketomi A; Maehara Y
J Gastroenterol Hepatol; 2010 May; 25(5):978-84. PubMed ID: 20546453
[TBL] [Abstract][Full Text] [Related]
9. Variation of the MELD score as a predictor of death on the waiting list for liver transplantation.
Gheorghe L; Iacob S; Iacob R; Gheorghe C; Popescu I
J Gastrointestin Liver Dis; 2007 Sep; 16(3):267-72. PubMed ID: 17925920
[TBL] [Abstract][Full Text] [Related]
10. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.
Ben-Haim M; Carmiel M; Katz P; Shabtai E; Oren R; Nakache R
Isr Med Assoc J; 2006 Sep; 8(9):605-9. PubMed ID: 17058408
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
[TBL] [Abstract][Full Text] [Related]
12. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area.
Xiol X; Gines P; Castells L; Twose J; Ribalta A; Fuentes-Arderiu X; Rodriguez S; Castellote J; Navasa M; Deulofeu R
Liver Transpl; 2009 Mar; 15(3):300-5. PubMed ID: 19242993
[TBL] [Abstract][Full Text] [Related]
13. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD
Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
[TBL] [Abstract][Full Text] [Related]
14. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
Silberhumer GR; Hetz H; Rasoul-Rockenschaub S; Peck-Radosavljevic M; Soliman T; Steininger R; Muehlbacher F; Berlakovich GA
Transpl Int; 2006 Apr; 19(4):275-81. PubMed ID: 16573542
[TBL] [Abstract][Full Text] [Related]
15. Model for end-stage liver disease (MELD) and allocation of donor livers.
Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
[TBL] [Abstract][Full Text] [Related]
16. Prognosis after liver transplantation predicted by preoperative MELD score.
Kim DJ; Lee SK; Jo JW; Kim SJ; Kwon CH; Park JW; Han YS; Park JB
Transplant Proc; 2006 Sep; 38(7):2095-6. PubMed ID: 16980010
[TBL] [Abstract][Full Text] [Related]
17. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
Cai CJ; Chen HA; Lu MQ; Chen GH
Chin Med J (Engl); 2008 Oct; 121(20):2065-9. PubMed ID: 19080277
[TBL] [Abstract][Full Text] [Related]
18. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.
Gheorghe L; Popescu I; Iacob R; Iacob S; Gheorghe C
Transpl Int; 2005 May; 18(5):572-6. PubMed ID: 15819806
[TBL] [Abstract][Full Text] [Related]
19. Survival benefit after liver transplantation: a single European center experience.
Ravaioli M; Grazi GL; Dazzi A; Bertuzzo V; Ercolani G; Cescon M; Cucchetti A; Masetti M; Ramacciato G; Pinna AD
Transplantation; 2009 Sep; 88(6):826-34. PubMed ID: 19920783
[TBL] [Abstract][Full Text] [Related]
20. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
Cuomo O; Perrella A; Arenga G
Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]